Your browser doesn't support javascript.
loading
Corrigendum: Bevacizumab-Irinotecan combination therapy in recurrent low-grade glioma, previously treated with chemo-radiotherapy: a case report.
Castelli, Barbara; Fonte, Carla; Guidi, Milena; Tellini, Marco; Di Nicola, Marco; Iacono, Alessandro; Buccoliero, Anna Maria; Greto, Daniela; Genitori, Lorenzo; Sardi, Iacopo.
  • Castelli B; Health Sciences Department, University of Florence, Florence, Italy.
  • Fonte C; Neuro-Oncology Unit, Meyer Children's Hospital IRCCS, Florence, Italy.
  • Guidi M; Neuro-Oncology Unit, Meyer Children's Hospital IRCCS, Florence, Italy.
  • Tellini M; Health Sciences Department, University of Florence, Florence, Italy.
  • Di Nicola M; Neuro-Oncology Unit, Meyer Children's Hospital IRCCS, Florence, Italy.
  • Iacono A; Neuro-Oncology Unit, Meyer Children's Hospital IRCCS, Florence, Italy.
  • Buccoliero AM; Neuro-Oncology Unit, Meyer Children's Hospital IRCCS, Florence, Italy.
  • Greto D; Radiology Unit, Meyer Children's Hospital IRCCS, Florence, Italy.
  • Genitori L; Pathology Unit, Meyer Children's Hospital IRCCS, Florence, Italy.
  • Sardi I; Radiotherapy Unit, University of Florence, Florence, Italy.
Front Oncol ; 14: 1372295, 2024.
Article en En | MEDLINE | ID: mdl-38361778
ABSTRACT
[This corrects the article DOI 10.3389/fonc.2023.1244628.].
Palabras clave